Investing Profile

Maina Bhaman

InvestorVC
Partner at Sofinnova Partners
Photo of Maina Bhaman, Partner at Soffinova Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
20
$548M
CompanyStageDateRound SizeTotal Raised
Purespring Therapeutics
Series BOct 2024$110M
$170M
Co-investors: Dominic Schmidt (Advent Life Sciences)
Myricx Bio
Series AJul 2024$120M
SeedNov 2020$6M
$120M
Co-investors: Stephen Thompson (Brandon Capital Partners), Jonathan Tobin (Brandon Capital Partners)
DISCO Pharmaceuticals
SeedJan 2024$22M
$22M
Co-investors: Therese Liechtenstein (M Ventures (Merck))
Mediar Therapeutics
Series AMar 2023$85M
$85M
Nuage Therapeutics
SeedMar 2023$13M
$13M
CinCor Pharma
Series BOct 2021$140M
Series AMay 2019$50M
$190M
Co-investors: James Healy (Sofinnova Investments), David Allison (Westlake Village BioPartners)
Catamaran Bio
Series ANov 2020$42M
$47M
Co-investors: Jack Kenney (SV Health Investors), Houman Ashrafian (SV Health Investors), Caroline Gaynor (Lightstone Ventures)
Sitryx Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Houman Ashrafian (SV Health Investors)